APA (7th ed.) Citation

Wang, G., Romero, Y., Thevarajan, I., & Zolkiewska, A. ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Wang, Guanpeng, Yeni Romero, Indhujah Thevarajan, and Anna Zolkiewska. ADAM12 Abrogation Alters Immune Cell Infiltration and Improves Response to Checkpoint Blockade Therapy in the T11 Murine Model of Triple-negative Breast Cancer. Taylor & Francis Group.

MLA (9th ed.) Citation

Wang, Guanpeng, et al. ADAM12 Abrogation Alters Immune Cell Infiltration and Improves Response to Checkpoint Blockade Therapy in the T11 Murine Model of Triple-negative Breast Cancer. Taylor & Francis Group.